Skip to content

Merging News

About
Contact
Home
Home
Privacy Policy

Merging News

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline – GlobeNewswire

Leave a Comment / Pharma and Biotech / By

Liminatus Pharma Amends Definitive combination pact with InnocsAI to Expand Oncology Cell Therapy Pipeline GlobeNewswire

Source: news.google.com

← Previous Post

Related Posts

Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc – PR Newswire

Day One Biopharmaceuticals to Acquire Mersana Therapeutics – GlobeNewswire

Leave a Comment Cancel Reply

Your email address will not be published. Required fields are marked *

Type here..

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Search

Recent Posts

Twins acquire RHP Tommy Nance from Blue Jays – Reuters
Burtech Acquisition Corp II Announces the Separate Trading – GlobeNewswire
Burtech Acquisition Corp II Announces the Separate Trading – GlobeNewswire
Mercator Acquisition Corp. Announces Closing of $172.5 Million Initial Public Offering – GlobeNewswire
Farm Supply Company and Grange Co-op Merger Approved by Shareholders – Business Wire

Recent Comments

No comments to show.

Archives

July 2026
June 2026
May 2026
April 2026
March 2026
February 2026
January 2026
December 2025
November 2025
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025
April 2025
March 2025
July 2024
March 2024
December 2023
October 2023
September 2023
August 2023
June 2023
May 2023

Categories

Bankruptcy
Energy and Materials
Financial Services
Mega Deals
Pharma and Biotech
Tech and Software

About
Contact
Home
Home
Privacy Policy

Sign up to receive email updates, fresh news and more!

There was an error trying to submit your form. Please try again.

This field is required.

There was an error trying to submit your form. Please try again.

Copyright © 2026 Merging News | Powered by Merging News